APP
EXAS

Alpha Paradigm Partners’s Exact Sciences EXAS Stock Holding History

Alpha Paradigm Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,943
Closed -$388K – 574
2021
Q1 		$388K Sell
2,943
-2,198
-43% -$301K 0.15% 200
2020
Q4 		$681K Buy
+5,141
New +$622K 0.24% 113

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alpha Paradigm Partners's EXAS Position: Q2 2021 in Review

Alpha Paradigm Partners sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 2,943 shares — an estimated $388K sold.

Alpha Paradigm Partners first reported a position in EXAS in Q4 2020 and held it in 2 quarters. The position peaked at $681K in Q4 2020. 622 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Alpha Paradigm Partners reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Alpha Paradigm Partners sold 2,943 Exact Sciences shares in Q2 2021, an estimated $388K.
  • Alpha Paradigm Partners first reported a position in Exact Sciences in Q4 2020 and held it in 2 quarters.
  • Alpha Paradigm Partners's Exact Sciences position peaked at $681K in Q4 2020.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Alpha Paradigm Partners's 13F filing for Q2 2021, filed 13 Aug 2021.